Use of FDA‐Approved Medications: Biologics for Psoriatic Arthritis in Patients at an Urban Outpatient Rheumatology Clinic

OBJECTIVE: Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that manifests as peripheral arthritis, dactylitis, enthesitis, and spondylitis. Biologics, particularly tumor necrosis factor inhibitors (TNFis) and some interleukin 17 (IL‐17) and interleukin 23 (IL‐23) inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanna, Ira, Kozicky, Orysia, Fischer, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857978/
https://www.ncbi.nlm.nih.gov/pubmed/31777842
http://dx.doi.org/10.1002/acr2.11077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857978/
https://www.ncbi.nlm.nih.gov/pubmed/31777842
http://dx.doi.org/10.1002/acr2.11077

Ejemplares similares